CELG News 86.55 10/16/2014 04:39:03 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 86.55 $CELG

Final Glance: Biotechnology companies
AP - Wed Oct 15, 5:07PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 96.16 (-1.02), AMGN: 130.90 (-1.30), CELG: 86.55 (+0.07)

Was Celgene's Crohn's Disease Drug Worth The Price?
at Investor's Business Daily - Wed Oct 15, 4:39PM CDT
Big-cap biotech Celgene made its name as a cancer fighter, but now it's branching out into diseases of the immune system. And one of the biggest tests of this new strategy comes this weekend. At the United European Gastroenterology Week in Vienna,...
JNJ: 98.21 (+1.20), ABBV: 54.63 (+0.50), CELG: 86.55 (+0.07)

Midday Glance: Biotechnology companies
AP - Wed Oct 15, 12:17PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 96.16 (-1.02), AMGN: 130.90 (-1.30), CELG: 86.55 (+0.07)

Early Glance: Biotechnology companies
AP - Wed Oct 15, 9:46AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 96.16 (-1.02), AMGN: 130.90 (-1.30), CELG: 86.55 (+0.07)

Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene
PR Newswire - Wed Oct 15, 8:10AM CDT
Investor-Edge has initiated coverage on the following equities: ImmunoGen Inc. (NASDAQ: IMGN), Arrowhead Research Corporation (NASDAQ: ARWR), Chimerix Inc. (NASDAQ: CMRX), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 14, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 16,315.19, down 0.04% and the NASDAQ Composite closed at 4,227.17, up 0.32%. The S&P 500 finished the session 0.16% higher at 1,877.70. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 705.81, down 0.76%, whereas the index has advanced 9.89% on YTD basis. Register for your complimentary reports on these five stocks at:
CMRX: 32.18 (+3.13), ARWR: 6.47 (+0.59), IMGN: 8.76 (+0.09), TKMR: 23.90 (+0.30), CELG: 86.55 (+0.07)

Celgene Set to Possibly Rebound After Yesterday's Selloff of 1.14%
Comtex SmarTrend(R) - Tue Oct 14, 3:43PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $85.62 to a high of $88.99. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $86.55 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 86.55 (+0.07)

After Yesterday's Decline of 1.14%, Celgene Offers Investors Better Value
Comtex SmarTrend(R) - Tue Oct 14, 3:43PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $85.62 to a high of $88.99. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $86.55 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 86.55 (+0.07)

Where Will Celgene Corporation Stock Be a Year From Now?
Motley Fool Staff - Motley Fool - Tue Oct 14, 11:20AM CDT
Source: Celgene. The markets have gotten a little panicky lately, so last week we asked some of our top analysts to tell us what they think are the  best companies to buy in a time of tumbling ticker tape . One pick was Celgene , a biotech...
JNJ: 98.21 (+1.20), PFE: 28.19 (-0.27), AMGN: 130.90 (-1.30), CELG: 86.55 (+0.07)

Acquisition, Market Activity, and Upcoming Events - Research Reports on Auxilium, Lakeland, Endo, Actavis and Celgene
PR Newswire - Tue Oct 14, 7:30AM CDT
Today, Analysts Review released its research reports regarding Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Lakeland Industries Inc. (NASDAQ: LAKE), Endo International plc (NASDAQ: ENDP), Actavis plc (NYSE: ACT) and Celgene Corporation (NASDAQ: CELG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7148-100free.
ENDP: 60.19 (-0.91), ACT: 217.24 (-4.83), QLTI: 3.96 (-0.09), AUXL: 30.41 (-0.46), LAKE: 23.60 (+2.17), CELG: 86.55 (+0.07), CELGZ: 3.52 (+0.09)

Apple, McKesson Among Big Caps In Trading Range
at Investor's Business Daily - Mon Oct 13, 5:38PM CDT
Many leading stocks have been forming flat bases as the market undergoes a series of fairly shallow pullbacks. In a flat base, a stock corrects 15% or less, with the ideal buy point typically 10 cents above the high of the left side. Leaders holding...
MCK: 185.02 (-3.60), GILD: 96.16 (-1.02), AAPL: 97.54 (-1.21), REGN: 334.75 (+6.68), CELG: 86.55 (+0.07)

Celgene's Otezla Encourages in Plaque Psoriasis at EADV - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 4:19PM CDT
Celgene (CELG) presented positive data on Otezla at the EADV.
MDVN: 89.63 (-1.68), SHPG: 170.49 (-74.08), REGN: 334.75 (+6.68), CELG: 86.55 (+0.07)

Cheap Stocks Wall Street Loves: Celgene Corporation
Selena Maranjian, The Motley Fool - Motley Fool - Mon Oct 13, 8:00AM CDT
Photo: Celgene Corporation. When looking for promising candidates for your portfolio, it makes sense to seek out undervalued, or cheap, stocks. Analysts on Wall Street do the same, and they slap ratings on thousands of stocks. Ratings are positive...
CELG: 86.55 (+0.07)

SmarTrend Watching for Potential Rebound in Shares of Celgene After 1.58% Loss
Comtex SmarTrend(R) - Fri Oct 10, 4:52PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $90.87 to a high of $93.85. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $91.54 on volume of 4.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 86.55 (+0.07)

New Analyses of Oral OTEZLA(R) (Apremilast) Presented at EADV Show Efficacy in Difficult-to-Treat Areas of Moderate to Severe Plaque Psoriasis
Business Wire - Fri Oct 10, 7:38AM CDT
--Improvements in pruritus (itching) seen as early as week 2 in analyses of ESTEEM 1 and 2 and maintained through week 32
CELG: 86.55 (+0.07)

Oral OTEZLA(R) (apremilast) Data Presented at EADV Show Improved Measures of Health-Related Quality of Life and Work Productivity in Patients with Moderate to Severe Plaque Psoriasis
Business Wire - Fri Oct 10, 7:37AM CDT
--Apremilast significantly increased work productivity and improved work limitations compared with placebo at week 16 in pooled analyses of ESTEEM 1 and 2
CELG: 86.55 (+0.07), CELGZ: 3.52 (+0.09)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 70

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 116

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 174

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
ATRenew's Q3 Profit Jump Meets a Cash Balance Test

Updated Category News Views 105

Used phones do not make for glamorous investing, but this quarter has some real muscle behind it. ATRenew turned a 25.3% revenue gain into a 57.9% jump in operating income for the three months ended September 30, and that is the sort of operating leverage I want to see before getting carried away with a circular-economy story. Margins Finally Move in the Right Direction...

Continue Reading
SQM Investigation Puts Chile Approval Claims on Trial

Updated Category News Views 9

A Regulatory Promise Meets a Rough Earnings Reaction A 5.52% haircut after disappointing quarterly numbers is the sort of thing that makes shareholders stop pretending every loose management comment is harmless. Sociedad Química y Minera de Chile, NYSE:SQM, is facing an investigation by Levi & Korsinsky into public statements concerning regulatory matters, particularly...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
T. Rowe Price Expands Teams Across 12 Fund Strategies

Updated Category News Views 73

A Quiet Personnel Shift With Real Stakes Twelve strategy changes may sound like administrative wallpaper, but asset managers live and die by who makes the calls. T. Rowe Price is broadening portfolio-management teams across equity and fixed-income offerings while insisting that each strategy's philosophy, process, and risk limits remain intact. Fine. That is the stated...

Continue Reading
Institutions Spread AI Bets as 2027 Risks Mount Higher

Updated Category News Views 89

Money managers are not fleeing the party; they are checking the fire exits. Natixis Investment Managers surveyed 515 institutions overseeing $42.7 trillion, and their 2027 posture is pretty plain: keep taking risk, just stop pretending every risk is the same. Inflation, rates, government debt, geopolitical fracture and an AI spending boom are all tugging at portfolios at...

Continue Reading
AT&T's Dec. 8 UBS Chat Puts Stankey's Updates on Watch

Updated Category News Views 160

A Small Slot With a Big Audience A calendar entry can still matter when the man holding the microphone runs AT&T. John Stankey, AT&T chairman and chief executive, is scheduled for a fireside chat at the UBS Global Media and Communications Conference on Tuesday, Dec. 8, beginning at 8:15 a.m. Eastern time. The company says the event will be webcast live through its...

Continue Reading
Point72 Breach Puts Cyber Controls Under the Microscope

Updated Category News Views 40

Two compromised user accounts can turn a supposedly contained cyber problem into a boardroom headache in a hurry. Point72 Asset Management, the global alternative-investment firm founded by Steven A. Cohen in 2014, has reported a social-engineering incident involving accounts that were used to copy files from limited portions of its IT systems. This is not a trading-loss...

Continue Reading

Top 5 Most Recently Viewed Articles

Critical Updates for iRobot Corporation Investors and Class Action

Updated Category News Views 128

Urgent Notice for iRobot Corporation Investors Attention to all investors of iRobot Corporation (NASDAQ: IRBT)! If you have purchased securities between January 29, 2024, and March 11, 2025, it is crucial to be aware of a significant deadline approaching on September 5, 2025. This notice aims to inform and guide you through this pressing matter. Why You Should Act Now The...

Continue Reading
NeuralTrust Expands to London as AI Risks Intensify

Updated Category News Views 26

NeuralTrust's Strategic London Expansion In a world where AI agents are sprinting ahead of our security instincts, NeuralTrust makes a big play in the UK market, locking in their position with a new London office. This move isn't just about expansion—it's about tackling the tide of challenges head-on that comes with putting AI agents into the wild. London: A Hub for...

Continue Reading
Virtu Financial Reports Strong Q3 2025 Performance Highlights

Updated Category News Views 227

Virtu Financial's Q3 2025 Financial Overview As of the end of the third quarter in 2025, Virtu Financial, Inc. (NYSE: VIRT), a prominent player in the financial services sector, reported impressive results showcasing their financial strength through market challenges. Performance Metrics at a Glance During the third quarter, Virtu experienced substantial growth with a net...

Continue Reading
Understanding Super Micro Computer's Options Activity Trends

Updated Category News Views 219

Understanding Super Micro Computer's Options Activity Trends Recent movements in the options market for Super Micro Computer (SMCI) have caught the attention of investors. The influx of significant bearish activities suggests a pivotal moment could be approaching for the company. Observing the options market can provide insights into potential stock behavior, something...

Continue Reading
HUAWEI AppGallery Promises Unforgettable Gaming at Gamescom

Updated Category News Views 318

Exciting Countdown to Gamescom 2025 One Week Countdown! Prepare for an exhilarating gaming adventure as HUAWEI AppGallery gears up for an unforgettable experience at Gamescom 2025! With just one week left, gamers are invited to immerse themselves in the excitement at Booth A.040. This event promises a fantastic blend of hands-on gameplay, vibrant community activations,...

Continue Reading